A phase 2b, randomized, double-mask, placebo-controlled, study to evaluate the safety, pharmacokinetics and efficacy of linsitinib in subjects with active, moderate to severe thyroid eye disease (TED)
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of BOTOX (Botulinum Toxin Type A) Purified Neurotoxin Complex for the Treatment of Upper Limb Essential Tremor
The Canadian Institutes of Health Research (CIHR) has announced the results of its Fall 2022 project grant competition. Congratulations to all the VCHRI researchers who were awarded project grants and priority announcement grants.
Humans are excellent at following objects with their eyes, such as a ball. However, we are less refined at tracking accelerating objects. New research led by Vancouver Coastal Health Research Institute researcher Dr. Miriam Spering provides a clearer picture of the mechanisms behind this very human hindrance.
Better long-term outcomes for people in need of treatment for atrial fibrillation may start with a cardiac procedure called cryoballoon ablation (cryoablation), according to a study led by Vancouver Coastal Health Research Institute researcher Dr. Jason Andrade.
Ultra-marathon running has been linked to the temporary lowering of cognition and memory, according to the findings of a study led by Vancouver Coastal Health Research Institute researcher, Dr. Darren Warburton.
“While the benefits of physical exercise far outweigh the risks, it is important to note the potential hazards associated with marathon running during and for a period of time following a race,” says Warburton. “Our research study enters into the territory of discovering what might be the upper limits of the benefits of exercise.”
Vancouver Coastal Health Research Institute (VCHRI) is proud to recognize the outstanding contributions of long-term research staff with this year’s inaugural Research Excellence Staff Award (RESA). This competition acknowledges staff members with 10 or more years of service who have demonstrated research excellence through mentorship, building research culture and upholding the VCHRI values of integrity, accountability, collaboration, equity and community- and patient-focus. Each recipient will receive $15,000 of lab funding, as well as a personal honorarium for their dedicated work.
Researchers at the Vancouver Prostate Centre have discovered that prostate cancer cells use a property in the androgen receptor to enhance the production and spread of the disease. The groundbreaking study, led by Vancouver Coastal Health Research Institute researcher Dr. Nada Lallous and Dr. Joerg Gsponer, and published in Nucleic Acids Research, lays the foundation to investigate novel therapies to target and destroy prostate cancer.
